Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 7 of 7 entries
Sorted by: Best Match Show Resources per page
[Methods of cytodiagnosis in internal medicine].

Vnitrni lekarstvi

Zeman V.
PMID: 6613039
Vnitr Lek. 1983 Jul;29(7):698-702.

No abstract available.

Cite
Zeman V. Metody cytodiagnostiky ve vnitrním lékarství. [Methods of cytodiagnosis in internal medicine]. Vnitr Lek. 1983;29(7):698-702
Zeman, V. (1983). Metody cytodiagnostiky ve vnitrním lékarství. [Methods of cytodiagnosis in internal medicine]. Vnitrni lekarstvi, 29(7), 698-702.
Zeman, V. "Metody cytodiagnostiky ve vnitrním lékarství." [Methods of cytodiagnosis in internal medicine]. Vnitrni lekarstvi vol. 29,7 (1983): 698-702.
Zeman V. Metody cytodiagnostiky ve vnitrním lékarství. [Methods of cytodiagnosis in internal medicine]. Vnitr Lek. 1983 Jul;29(7):698-702. Czech. PMID: 6613039.
Copy Download .nbib Format: NLM
Our 2017 Cancer Cytopathology Young Investigator.

Cancer cytopathology

Powers CN.
PMID: 29451747
Cancer Cytopathol. 2018 Feb;126(2):83-85. doi: 10.1002/cncy.21961.

No abstract available.

Cite
Powers CN. Our 2017 Cancer Cytopathology Young Investigator. Cancer Cytopathol. 2018;126(2):83-85doi: 10.1002/cncy.21961.
Powers, C. N. (2018). Our 2017 Cancer Cytopathology Young Investigator. Cancer cytopathology, 126(2), 83-85. https://doi.org/10.1002/cncy.21961
Powers, Celeste N. "Our 2017 Cancer Cytopathology Young Investigator." Cancer cytopathology vol. 126,2 (2018): 83-85. doi: https://doi.org/10.1002/cncy.21961
Powers CN. Our 2017 Cancer Cytopathology Young Investigator. Cancer Cytopathol. 2018 Feb;126(2):83-85. doi: 10.1002/cncy.21961. PMID: 29451747.
Copy Download .nbib Format: NLM
Risk-benefit analysis of sampling methods for fine-needle aspiration cytology: a mathematical modeling approach.

American journal of clinical pathology

Schmidt RL, Kordy MA, Howard K, Layfield LJ, Hall BJ, Adler DG.
PMID: 23429370
Am J Clin Pathol. 2013 Mar;139(3):336-44. doi: 10.1309/AJCPEAKR4MO2GQBO.

The effectiveness of fine-needle aspiration (FNA) increases with the number of needle passes, but needle passes are also associated with increased risk of adverse events. The trade-off between needle passes and adequacy has not been well characterized. Clinical studies...

Cite
Schmidt RL, Kordy MA, Howard K, et al. Risk-benefit analysis of sampling methods for fine-needle aspiration cytology: a mathematical modeling approach. Am J Clin Pathol. 2013;139(3):336-44doi: 10.1309/AJCPEAKR4MO2GQBO.
Schmidt, R. L., Kordy, M. A., Howard, K., Layfield, L. J., Hall, B. J., & Adler, D. G. (2013). Risk-benefit analysis of sampling methods for fine-needle aspiration cytology: a mathematical modeling approach. American journal of clinical pathology, 139(3), 336-44. https://doi.org/10.1309/AJCPEAKR4MO2GQBO
Schmidt, Robert L, et al. "Risk-benefit analysis of sampling methods for fine-needle aspiration cytology: a mathematical modeling approach." American journal of clinical pathology vol. 139,3 (2013): 336-44. doi: https://doi.org/10.1309/AJCPEAKR4MO2GQBO
Schmidt RL, Kordy MA, Howard K, Layfield LJ, Hall BJ, Adler DG. Risk-benefit analysis of sampling methods for fine-needle aspiration cytology: a mathematical modeling approach. Am J Clin Pathol. 2013 Mar;139(3):336-44. doi: 10.1309/AJCPEAKR4MO2GQBO. PMID: 23429370.
Copy Download .nbib Format: NLM
Cancer cytopathology 2010: leading the way into the future.

Cancer cytopathology

Powers CN.
PMID: 21113922
Cancer Cytopathol. 2010 Oct 25;118(5):229-32. doi: 10.1002/cncy.20107.

No abstract available.

Cite
Powers CN. Cancer cytopathology 2010: leading the way into the future. Cancer Cytopathol. 2010;118(5):229-32doi: 10.1002/cncy.20107.
Powers, C. N. (2010). Cancer cytopathology 2010: leading the way into the future. Cancer cytopathology, 118(5), 229-32. https://doi.org/10.1002/cncy.20107
Powers, Celeste N. "Cancer cytopathology 2010: leading the way into the future." Cancer cytopathology vol. 118,5 (2010): 229-32. doi: https://doi.org/10.1002/cncy.20107
Powers CN. Cancer cytopathology 2010: leading the way into the future. Cancer Cytopathol. 2010 Oct 25;118(5):229-32. doi: 10.1002/cncy.20107. PMID: 21113922.
Copy Download .nbib Format: NLM
Gastrointestinal tract cytology: advancing horizons.

Advances in anatomic pathology

Jhala N, Jhala D.
PMID: 12973048
Adv Anat Pathol. 2003 Sep;10(5):261-77. doi: 10.1097/00125480-200309000-00002.

Tide and ebb of interest in gastrointestinal tract cytology has followed technical advances in this field over the last 60 years. Cytologic samples can be obtained using gastric lavage, abrasive balloons, mucosal brushing, and fine needle aspiration (under percutaneous...

Cite
Jhala N, Jhala D. Gastrointestinal tract cytology: advancing horizons. Adv Anat Pathol. 2003;10(5):261-77doi: 10.1097/00125480-200309000-00002.
Jhala, N., & Jhala, D. (2003). Gastrointestinal tract cytology: advancing horizons. Advances in anatomic pathology, 10(5), 261-77. https://doi.org/10.1097/00125480-200309000-00002
Jhala, Nirag, and Jhala, Darshana. "Gastrointestinal tract cytology: advancing horizons." Advances in anatomic pathology vol. 10,5 (2003): 261-77. doi: https://doi.org/10.1097/00125480-200309000-00002
Jhala N, Jhala D. Gastrointestinal tract cytology: advancing horizons. Adv Anat Pathol. 2003 Sep;10(5):261-77. doi: 10.1097/00125480-200309000-00002. PMID: 12973048.
Copy Download .nbib Format: NLM
Technical and US regulatory issues in triaging material for the molecular laboratory.

Cancer cytopathology

Fischer AH, Hutchinson LM.
PMID: 27598019
Cancer Cytopathol. 2017 Feb;125(2):83-90. doi: 10.1002/cncy.21774. Epub 2016 Sep 06.

No abstract available.

Cite
Fischer AH, Hutchinson LM. Technical and US regulatory issues in triaging material for the molecular laboratory. Cancer Cytopathol. 2016;125(2):83-90doi: 10.1002/cncy.21774.
Fischer, A. H., & Hutchinson, L. M. (2017). Technical and US regulatory issues in triaging material for the molecular laboratory. Cancer cytopathology, 125(2), 83-90. https://doi.org/10.1002/cncy.21774
Fischer, Andrew H, and Hutchinson, Lloyd M. "Technical and US regulatory issues in triaging material for the molecular laboratory." Cancer cytopathology vol. 125,2 (2017): 83-90. doi: https://doi.org/10.1002/cncy.21774
Fischer AH, Hutchinson LM. Technical and US regulatory issues in triaging material for the molecular laboratory. Cancer Cytopathol. 2017 Feb;125(2):83-90. doi: 10.1002/cncy.21774. Epub 2016 Sep 06. PMID: 27598019.
Copy Download .nbib Format: NLM
Gladwyn Leiman: An appreciation.

Cancer cytopathology

Powers CN.
PMID: 27294406
Cancer Cytopathol. 2016 Jun;124(6):373-4. doi: 10.1002/cncy.21732.

No abstract available.

Cite
Powers CN. Gladwyn Leiman: An appreciation. Cancer Cytopathol. 2016;124(6):373-4doi: 10.1002/cncy.21732.
Powers, C. N. (2016). Gladwyn Leiman: An appreciation. Cancer cytopathology, 124(6), 373-4. https://doi.org/10.1002/cncy.21732
Powers, Celeste N. "Gladwyn Leiman: An appreciation." Cancer cytopathology vol. 124,6 (2016): 373-4. doi: https://doi.org/10.1002/cncy.21732
Powers CN. Gladwyn Leiman: An appreciation. Cancer Cytopathol. 2016 Jun;124(6):373-4. doi: 10.1002/cncy.21732. PMID: 27294406.
Copy Download .nbib Format: NLM
Showing 1 to 7 of 7 entries